Prognostic Value of a Multivariate Gut Microbiome Model for Progression from Normal Cognition to Mild Cognitive Impairment Within 4 Years
Little is known about the dysbiosis of the gut microbiome in patients with mild cognitive impairment (MCI) potentially at risk for the development of Alzheimer's disease (AD). So far, only cross-sectional differences and not longitudinal changes and their prognostic significance have been in the scope of research in MCI. Therefore, we investigated the ability of longitudinal taxonomic and functional gut microbiome data from 100 healthy controls (HC) to predict the progression from normal cognition to MCI over a 4-year follow-up period (4yFU). Logistic regression models were built with baseline features that best discriminated between the two groups using an ANOVA-type statistical analysis. The best model for the discrimination of MCI converters was based on functional data using Gene Ontology (GO), which included 14 features. This model achieved an area under the receiver operating characteristic curve (AUROC) of 0.84 at baseline, 0.78 at the 1-year follow-up (1yFU), and 0.75 at 4yFU. This functional model outperformed the taxonomic model, which included 38 genera features, in terms of descriptive performance and showed comparable efficacy to combined analyses integrating functional, taxonomic, and clinical characteristics. Thus, gut microbiome algorithms have the potential to predict MCI conversion in HCs over a 4-year period, offering a promising innovative supplement for early AD identification.
Authors
- Ulrich Schoppmeier
- Iris Honold
- Silke Peter (ORCID: https://orcid.org/0000-0002-1355-3953)
- Anne Bauch (ORCID: https://orcid.org/0000-0003-4661-2523)
- Gerhard Weber (ORCID: https://orcid.org/0000-0002-1890-4281)
- Julia Baur (ORCID: https://orcid.org/0000-0002-5218-7757)
- Stephan A. Müller (ORCID: https://orcid.org/0000-0003-3414-307X)
- Matthias Willmann (ORCID: https://orcid.org/0000-0003-0095-4640)
- Sebastian Sodenkamp
- Christoph Laske
Institutions
- German Center for Neurodegenerative Diseases (DE)
- Roto Frank (Germany) (DE)
- Institute of Medical Microbiology and Hygiene (DE)
- Hertie Institute for Clinical Brain Research (DE)
- Bayer (Germany) (DE)
- University of Tübingen (DE)
Publication Details
- Journal
- International Journal of Molecular Sciences
- Published
- 2025-05-15
- DOI
- https://doi.org/10.3390/ijms26104735
- Citations
- 1
- Primary Topic
- Diet and metabolism studies
- Type
- article
- Field-Weighted Citation Impact
- 1.16
Funders
- Eberhard Karls Universität Tübingen